Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP613114.RAWIcDD1SokWdFJhxE8GF5dlyCTR_FRzbt_33hv8gc98g130_assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP613114.RAWIcDD1SokWdFJhxE8GF5dlyCTR_FRzbt_33hv8gc98g130_provenance.
• NP246859.RA-zrf6qWRH4LKCCH3VzbOH-PbT-a07iLeJOFhDN6NXJ8130_assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP246859.RA-zrf6qWRH4LKCCH3VzbOH-PbT-a07iLeJOFhDN6NXJ8130_provenance.
• NP255052.RA584nNoaVcDI0htuECCHY9v7GZG0K_kqAiagN-VL6J58130_assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP255052.RA584nNoaVcDI0htuECCHY9v7GZG0K_kqAiagN-VL6J58130_provenance.
• assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP544260.RAlTBIqkmFT0-3Tu0zMTIV-IXnLeKDmGfBWreg7MMTwLY130_assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP544260.RAlTBIqkmFT0-3Tu0zMTIV-IXnLeKDmGfBWreg7MMTwLY130_provenance.
• NP194582.RAgXLig6_HRlIdRF-eWC7dg35Nj8RJylMZ3bb2GuaXvYg130_assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP194582.RAgXLig6_HRlIdRF-eWC7dg35Nj8RJylMZ3bb2GuaXvYg130_provenance.
• NP560968.RATShZ2dmrfangAphl3eYhsvsqpgB5oDccf71w4Ges_Y0130_assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP560968.RATShZ2dmrfangAphl3eYhsvsqpgB5oDccf71w4Ges_Y0130_provenance.
• NP811980.RAyUUqOvkl6Kta3J-uGtH1nB_zOLeRGWicD56t7NhIxZs130_assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP811980.RAyUUqOvkl6Kta3J-uGtH1nB_zOLeRGWicD56t7NhIxZs130_provenance.
• NP789531.RA4uXZYZioORsVs5V2-HGidoH_CnwJKOuhZ-A7EeAVS4c130_assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789531.RA4uXZYZioORsVs5V2-HGidoH_CnwJKOuhZ-A7EeAVS4c130_provenance.
• NP890481.RARINNPseLwHvsmD0zmwdBQ1zWaLpb6Z8Ssozh4w-89QU130_assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP890481.RARINNPseLwHvsmD0zmwdBQ1zWaLpb6Z8Ssozh4w-89QU130_provenance.
• NP469002.RAE7NCjESN3P89i2R_FPQsX2JOXnj0EMncixduK5wB6NM130_assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP469002.RAE7NCjESN3P89i2R_FPQsX2JOXnj0EMncixduK5wB6NM130_provenance.
• assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1057085.RAYMIkCXoqXbiOy1mQ_Ddz9CaXp5rw1Bi25_JoJ0cj6aQ130_assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1057085.RAYMIkCXoqXbiOy1mQ_Ddz9CaXp5rw1Bi25_JoJ0cj6aQ130_provenance.
• NP1057084.RADP0kIV14Xy7agtEDbFg8XeDfSWfPgGfyTDCoO57hAQ4130_assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1057084.RADP0kIV14Xy7agtEDbFg8XeDfSWfPgGfyTDCoO57hAQ4130_provenance.
• NP890504.RAqqrX1AIBme9CLK9cIX9xBQmzdZjvRzfi2alYySc7yp8130_assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP890504.RAqqrX1AIBme9CLK9cIX9xBQmzdZjvRzfi2alYySc7yp8130_provenance.
• NP1057091.RAnCy8_iHsyDdg1CUAg6vH83OeyTl2dWYj4FcIoiFgDmQ130_assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1057091.RAnCy8_iHsyDdg1CUAg6vH83OeyTl2dWYj4FcIoiFgDmQ130_provenance.
• NP235378.RA4L5QfwvlsP8-EzEMEHZi6M9JVCNLSMcM--dSMI2TRTs130_assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP235378.RA4L5QfwvlsP8-EzEMEHZi6M9JVCNLSMcM--dSMI2TRTs130_provenance.
• NP235603.RAOzIwHUEUg8miJ0rpeEJyrOtoPnZ8_y9J6amo93Z2KZk130_assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP235603.RAOzIwHUEUg8miJ0rpeEJyrOtoPnZ8_y9J6amo93Z2KZk130_provenance.
• NP1057087.RAEhIeg1EkJvT0scEpLuGsunrz041Z-mtUBj7rP3gKvCM130_assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1057087.RAEhIeg1EkJvT0scEpLuGsunrz041Z-mtUBj7rP3gKvCM130_provenance.
• NP1057089.RAHFKxULRWRw4tgqFUnmM2puA4QilB4L9QzBvg2L6zfC8130_assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1057089.RAHFKxULRWRw4tgqFUnmM2puA4QilB4L9QzBvg2L6zfC8130_provenance.
• NP1057092.RA0F8Nl8z-lV1AlMqDfR2FUoKU0Mzf10lzEbYqYS0uHio130_assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1057092.RA0F8Nl8z-lV1AlMqDfR2FUoKU0Mzf10lzEbYqYS0uHio130_provenance.
• NP890501.RA7j3DK9VnRwOEyeetP7ceiWz2A0viKRrmc0vVbNSuFbw130_assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP890501.RA7j3DK9VnRwOEyeetP7ceiWz2A0viKRrmc0vVbNSuFbw130_provenance.
• NP890503.RA4J41JrAZQyCGeZJcI7XY_rOMZH3ZuX0_CasmJ4p-B54130_assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP890503.RA4J41JrAZQyCGeZJcI7XY_rOMZH3ZuX0_CasmJ4p-B54130_provenance.